The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options (original) (raw)
Withrow D, Alter DA . The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obes Rev 2011; 12: 131–141. ArticleCASPubMed Google Scholar
Skidmore PM, Yarnell JW . The obesity epidemic: prospects for prevention. QJM 2004; 97: 817–825. ArticleCASPubMed Google Scholar
Qi L, Cho YA . Gene-environment interaction and obesity. Nutr Rev 2008; 66: 684–694. ArticlePubMed Google Scholar
Moore CJ, Cunningham SA . Social position, psychological stress, and obesity: a systematic review. J Acad Nutr Diet 2012; 112: 518–526. ArticlePubMed Google Scholar
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS . Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68–100. CASPubMed Google Scholar
Hess S, Linde Y, Ovadia O, Safrai E, Shalev DE, Swed A et al. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J Med Chem 2008; 51: 1026–1034. ArticleCASPubMed Google Scholar
van den Berg L, Glorie-Docter M, van den Akker E, Delemarre-van de Waal HA . Obesity caused by melanocortin-4 receptor mutations. Ned Tijdschr Geneeskd 2012; 156: A4548. PubMed Google Scholar
Rene P, Le Gouill C, Pogozheva ID, Lee G, Mosberg HI, Farooqi IS et al. Pharmacological chaperones restore function to MC4R mutants responsible for severe early-onset obesity. J Pharmacol Exp Ther 2010; 335: 520–532. ArticleCASPubMed Google Scholar
Hansen MJ, Schioth HB, Morris MJ . Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet. Brain Res 2005; 1039: 137–145. ArticleCASPubMed Google Scholar
Getting SJ . Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 2006; 111: 1–15. ArticleCASPubMed Google Scholar
Ye Z, MacNeil T, Weinberg DH, Kalyani RN, Tang R, Strack AM et al. Structure-activity relationship of linear tetrapeptides Tic-DPhe-Arg-Trp-NH2 at the human melanocortin-4 receptor and effects on feeding behaviors in rat. Peptides 2005; 26: 2017–2025. ArticleCASPubMed Google Scholar
He S, Ye Z, Dobbelaar PH, Sebhat IK, Guo L, Liu J et al. Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity. Bioorg Med Chem Lett 2010; 20: 4399–4405. ArticleCASPubMed Google Scholar
He S, Ye Z, Dobbelaar PH, Bakshi RK, Hong Q, Dellureficio JP et al. Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity. Bioorg Med Chem Lett 2010; 20: 6524–6532. ArticleCASPubMed Google Scholar
Krishna R, Gumbiner B, Stevens C, Musser B, Mallick M, Suryawanshi S et al. Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy. Clin Pharmacol Ther 2009; 86: 659–666. ArticleCASPubMed Google Scholar
Hong Q, Bakshi RK, Palucki BL, Park MK, Ye Z, He S et al. Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist. Bioorg Med Chem Lett 2011; 21: 2330–2334. ArticleCASPubMed Google Scholar
Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA et al. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. J Neurosci 2000; 20: 3442–3448. ArticleCASPubMedPubMed Central Google Scholar
Conde-Frieboes K, Ankersen M, Breinholt J, Hansen BS, Raun K, Thogersen H et al. Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes. Bioorg Med Chem Lett 2011; 21: 1459–1463. ArticleCASPubMed Google Scholar
Al-Barazanji KA, Miller JE, Rice SQ, Arch JR, Chambers JK . C-terminal fragments of ACTH stimulate feeding in fasted rats. Horm Metab Res 2001; 33: 480–485. ArticleCASPubMed Google Scholar
Cepoi D, Phillips T, Cismowski M, Goodfellow VS, Ling N, Cone RD et al. Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis. Brain Res 2004; 1000: 64–71. ArticleCASPubMed Google Scholar
Chen C, Jiang W, Tran JA, Tucci FC, Fleck BA, Markison S et al. Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor. Bioorg Med Chem Lett 2008; 18: 129–136. ArticleCASPubMed Google Scholar
Kumar KG, Sutton GM, Dong JZ, Roubert P, Plas P, Halem HA et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides 2009; 30: 1892–1900. ArticleCASPubMedPubMed Central Google Scholar
Hsiung HM, Hertel J, Zhang XY, Smith DP, Smiley DL, Heiman ML et al. A novel and selective beta-melanocyte-stimulating hormone-derived peptide agonist for melanocortin 4 receptor potently decreased food intake and body weight gain in diet-induced obese rats. Endocrinology 2005; 146: 5257–5266. ArticleCASPubMed Google Scholar
Hsiung HM, Smiley DL, Zhang XY, Zhang L, Yan LZ, Craft L et al. Potent peptide agonists for human melanocortin 3 and 4 receptors derived from enzymatic cleavages of human beta-MSH(5-22) by dipeptidyl peptidase I and dipeptidyl peptidase IV. Peptides 2005; 26: 1988–1996. ArticleCASPubMed Google Scholar
Wessells H, Hruby VJ, Hackett J, Han G, Balse-Srinivasan P, Vanderah TW . MT-II induces penile erection via brain and spinal mechanisms. Ann N Y Acad Sci 2003; 994: 90–95. ArticleCASPubMed Google Scholar
Kievit P, Halem H, Marks DL, Dong JZ, Glavas MM, Sinnayah P et al. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes 2013; 62: 490–497. ArticleCASPubMedPubMed Central Google Scholar
Linde Y, Ovadia O, Safrai E, Xiang Z, Portillo FP, Shalev DE et al. Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers 2008; 90: 671–682. ArticleCASPubMedPubMed Central Google Scholar
Granell S, Mohammad S, Ramanagoudr-Bhojappa R, Baldini G . Obesity-linked variants of melanocortin-4 receptor are misfolded in the endoplasmic reticulum and can be rescued to the cell surface by a chemical chaperone. Mol Endocrinol 2010; 24: 1805–1821. ArticleCASPubMedPubMed Central Google Scholar
Ward KR, Bardgett JF, Wolfgang L, Stocker SD . Sympathetic response to insulin is mediated by melanocortin 3/4 receptors in the hypothalamic paraventricular nucleus. Hypertension 2011; 57: 435–441. ArticleCASPubMed Google Scholar
Roubert P, Dubern B, Plas P, Lubrano-Berthelier C, Alihi R, Auger F et al. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response. J Endocrinol 2010; 207: 177–183. ArticleCASPubMed Google Scholar
Raun K, Dahl K, Nilsson C, Voss PV, Fosgerau K, Conde-Frieboes KW et al. Novel MC4 agonist peptide effectively reduces body weight in diet-induced obese rats and minipigs. Obesity 2011; 19: S179. Article Google Scholar
Raun K, Conde-Frieboes KW, Sensfuss U, Wulff BS . A long acting, selective MC4 receptor agonist effectively reduces appetite and bodyweight in diet induced obese rats. Obes Rev 2011; 12: 279. Google Scholar
Colman E, Golden J, Roberts M, Egan A, Weaver J, Rosebraugh C . The FDA’s assessment of two drugs for chronic weight management. N Engl J Med 2012; 367: 1577–1579. ArticleCASPubMed Google Scholar
Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010; 363: 245–256. ArticleCASPubMed Google Scholar